Code-N has recently added three distinguished executives to its advisory board. We’ll be introducing them and their specific takes on Code-N in upcoming blog posts. First up is Christian Fibiger, chief scientific officer at MedGenesis Therapeutix. We began by asking Chris about what he sees as the primary challenges impeding modern drug discovery and development. Databases […]
Read more »